Giovanni Caforio
CIK 1533201 · Executive Chair of the Board · last filed 2026-05-08
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$22.65M
Companies
4
Total Filings
61
Lifetime Open-Market Net
-$46.80M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SYK | Director | 4,530 | $312.20 | $1.41M | $0 | 8 | 2026-05-08 |
| CELGr | Executive Chair of the Board | 400,946 | $0.12 | $49.3K | -$36.21M | 16 | 2024-03-12 |
| BMY | Chairman and CEO | 370,840 | $57.13 | $21.19M | -$6.83M | 25 | 2019-05-06 |
| BRISTOL MYERS SQUIBB CO (BMYp) Delisted | Pres., US Pharmaceuticals | 47,316 | — | — | -$3.76M | 12 | 2013-05-31 |
Recent Filings · Page 2 of 7
61 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-09-16 | CELGr | Sell (S) | −50,000 | -$3.59M | EDGAR |
| 2022-06-14 | CELGr | Sell (S) | −30,000 | -$2.22M | EDGAR |
| 2022-05-06 | SYK | Mixed | +693 | $0 | EDGAR |
| 2022-03-23 | CELGr | Mixed | −25,420 | -$1.79M | EDGAR |
| 2022-03-14 | CELGr | Mixed | +153,069 | -$10.87M | EDGAR |
| 2022-02-28 | CELGr | Sell (S) | −30,000 | -$2.01M | EDGAR |
| 2021-09-22 | CELGr | Sell (S) | −25,000 | -$1.52M | EDGAR |
| 2021-08-04 | CELGr | Sell (S) | −20,000 | -$1.37M | EDGAR |
| 2021-05-07 | SYK | Grant (A) | — | $0 | EDGAR |
| 2021-03-24 | CELGr | Sell (S) | −25,000 | -$1.55M | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.